Company Filing History:
1 out of 2 
1 out of 454 
1 out of 1 Years Active: 2021
Title: Bruno Almeida Cotrim: Innovator in Fatty Acid Amides
Introduction
Bruno Almeida Cotrim is a notable inventor based in Barcelona, Spain. He has made significant contributions to the field of biomedical research, particularly in the prevention and treatment of liver diseases. His innovative work has led to the development of a patent that addresses critical health issues related to fatty liver conditions.
Latest Patents
Cotrim holds a patent for "Fatty acid amides for the prevention and/or treatment of steatohepatitis." This invention focuses on the use of fatty acid amides combined with phenylalkylamines in a pharmaceutical composition. The aim is to prevent and treat fatty liver diseases, including both alcoholic and non-alcoholic steatohepatitis (NASH). This patent highlights his commitment to advancing medical treatments for liver-related health issues.
Career Highlights
Throughout his career, Cotrim has worked with esteemed organizations such as the Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud (Fimabis) and the Consejo Superior de Investigaciones Científicas. His roles in these institutions have allowed him to engage in groundbreaking research and contribute to the scientific community.
Collaborations
Cotrim has collaborated with notable colleagues, including Fernando Rodríguez De Fonseca and Francisco Javier Pavón Morón. These partnerships have enriched his research endeavors and fostered innovation in the field of biomedicine.
Conclusion
Bruno Almeida Cotrim is a distinguished inventor whose work in fatty acid amides has the potential to significantly impact the treatment of liver diseases. His dedication to research and collaboration with other experts underscores his importance in the biomedical field.